Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
9
Number of overlapping holdings
13.8%
% of XLV's 65 holdings also in XPH
24.3%
% of XPH's 40 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 9.2% | 5.6% | 5.6% |
|
MERCK & CO. INC. | 5.5% | 4.2% | 4.2% |
|
JOHNSON & JOHNSON | 7.9% | 4.0% | 4.0% |
|
PFIZER INC | 3.9% | 3.8% | 3.8% |
|
BRISTOL-MYERS SQUIBB CO | 2.5% | 3.9% | 2.5% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to XPH
|
UNITEDHEALTH GROUP INC | 9.2% |
|
ABBVIE INC | 5.4% |
|
THERMO FISHER SCIENTIFIC INC | 4.0% |
|
JOHNSON & JOHNSON | 3.9% |
|
ELI LILLY & CO | 3.6% |
|
ABBOTT LABORATORIES | 3.6% |
|
DANAHER CORP | 3.4% |
|
AMGEN INC | 2.8% |
 |
MEDTRONIC PLC | 2.2% |
|
ANTHEM INC | 2.1% |
XLV Underweight Relative to XPH
|
REATA PHARMACEUTICALS, INC. CLASS A | -7.9% |
|
ELANCO ANIMAL HEALTH, INC. | -5.7% |
|
CATALENT INC | -5.3% |
|
JAZZ PHARMACEUTICALS PLC | -4.5% |
|
AXSOME THERAPEUTICS, INC. | -4.4% |
|
VIATRIS, INC. | -4.3% |
|
ORGANON & CO. | -3.7% |
|
PERRIGO CO | -3.7% |
|
ROYALTY PHARMA PLC CLASS A | -3.7% |
|
INTRA-CELLULAR THERAPIES INC | -3.6% |